FABRY DISEASE - AN UNUSUAL CAUSE OF SEVERE CORONARY-DISEASE IN A YOUNG MAN
被引:27
作者:
FISHER, EA
论文数: 0引用数: 0
h-index: 0
机构:
MT SINAI MED CTR, DIV CARDIOL, BOX 1030, 1 GUSTAVE L LEVY PL, NEW YORK, NY 10029 USAMT SINAI MED CTR, DIV CARDIOL, BOX 1030, 1 GUSTAVE L LEVY PL, NEW YORK, NY 10029 USA
FISHER, EA
[1
]
DESNICK, RJ
论文数: 0引用数: 0
h-index: 0
机构:
MT SINAI MED CTR, DIV CARDIOL, BOX 1030, 1 GUSTAVE L LEVY PL, NEW YORK, NY 10029 USAMT SINAI MED CTR, DIV CARDIOL, BOX 1030, 1 GUSTAVE L LEVY PL, NEW YORK, NY 10029 USA
DESNICK, RJ
[1
]
GORDON, RE
论文数: 0引用数: 0
h-index: 0
机构:
MT SINAI MED CTR, DIV CARDIOL, BOX 1030, 1 GUSTAVE L LEVY PL, NEW YORK, NY 10029 USAMT SINAI MED CTR, DIV CARDIOL, BOX 1030, 1 GUSTAVE L LEVY PL, NEW YORK, NY 10029 USA
GORDON, RE
[1
]
ENG, CM
论文数: 0引用数: 0
h-index: 0
机构:
MT SINAI MED CTR, DIV CARDIOL, BOX 1030, 1 GUSTAVE L LEVY PL, NEW YORK, NY 10029 USAMT SINAI MED CTR, DIV CARDIOL, BOX 1030, 1 GUSTAVE L LEVY PL, NEW YORK, NY 10029 USA
ENG, CM
[1
]
GRIEPP, R
论文数: 0引用数: 0
h-index: 0
机构:
MT SINAI MED CTR, DIV CARDIOL, BOX 1030, 1 GUSTAVE L LEVY PL, NEW YORK, NY 10029 USAMT SINAI MED CTR, DIV CARDIOL, BOX 1030, 1 GUSTAVE L LEVY PL, NEW YORK, NY 10029 USA
GRIEPP, R
[1
]
GOLDMAN, ME
论文数: 0引用数: 0
h-index: 0
机构:
MT SINAI MED CTR, DIV CARDIOL, BOX 1030, 1 GUSTAVE L LEVY PL, NEW YORK, NY 10029 USAMT SINAI MED CTR, DIV CARDIOL, BOX 1030, 1 GUSTAVE L LEVY PL, NEW YORK, NY 10029 USA
GOLDMAN, ME
[1
]
机构:
[1] MT SINAI MED CTR, DIV CARDIOL, BOX 1030, 1 GUSTAVE L LEVY PL, NEW YORK, NY 10029 USA
Fabry disease is an X-linked recessive disease resulting from deficient activity of alpha-galactosidse A. This deficiencY leads to the accumulation of glycosphingolipids in the lysosomes of vascular endothelial and smooth muscle cells. In classically affected men, skin manifestations begin by adolescence, and, with advancing age, vascular deposition in small vessels throughout the body leads to end-organ involvement of the kidney, heart, and brain. We report the case of a patient who had clinically significant coronary artery disease as the initial presentation of end-organ involvement and who was treated with bypass surgery.